You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Update Protocol Preventive Antibiotics in Stroke Study (PASS)

International Journal of Stroke

Impact Factor: 8.7 / 5-Year Impact Factor: 6.9

Journal Homepage Submission guidelines

Restricted access

Letter

First published online July, 2014

Update Protocol Preventive Antibiotics in Stroke Study (PASS)

and

Volume 9, Issue 5

https://doi.org/10.1111/ijs.12285

Abstract

Get full access to this article

View all access options for this article.

References

1.

Nederkoorn

PJ

Westendorp

WF

Hooijenga

IJ

. Preventive antibiotics in stroke study: Rationale and protocol for a randomised trial. Int J Stroke 2011; 6: 159–63.

2.

Bath

PM

Gray

LJ

Collier

T

Pocock

S

Carpenter

J

. Can we improve the statistical analysis of stroke trials? Statistical reanalysis of functional outcomes in stroke trials. Stroke 2007; 38: 1911–5.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

Ticagrelor plus aspirin versus cilostazol plus aspirin in the acute-phase treatment of large-vessel minor stroke or TIA: A randomized controlled multi-center trial,the TACTIS trial

Free access

Arterial branching and basal ganglia lacunes: A study in pure small vessel disease

Free access

Patients with acute stroke are less likely to be admitted directly to a stroke unit when hospital beds are scarce: A Swedish multicenter register study

Retricted access

Single versus dual antiplatelet therapy for stroke prevention in patients with first-ever embolic stroke of undetermined source